| Diana Ruth Rankin, MS | |
|
131 N Santa Fe Ave Ste 1a, Salina, KS 67401-2642 | |
| (785) 823-1245 | |
| (785) 823-1940 |
| Full Name | Diana Ruth Rankin |
|---|---|
| Gender | Female |
| Speciality | Psychologist - Counseling |
| Location | 131 N Santa Fe Ave Ste 1a, Salina, Kansas |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1518147727 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 103TC1900X | Psychologist - Counseling | 1109 (Kansas) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Diana Ruth Rankin, MS 131 N Santa Fe Ave Ste 1a, Salina, KS 67401-2642 Ph: (785) 823-1245 | Diana Ruth Rankin, MS 131 N Santa Fe Ave Ste 1a, Salina, KS 67401-2642 Ph: (785) 823-1245 |
News Archive
In what could be a pivotal step toward repairing non-healing wounds and damaged organs, a Drexel University biomedical engineer has identified an immune cell as a potential strategy for growing blood vessels.
A new Dartmouth-led study, published this week in the journal Pediatrics, has found that the disproportionate use of premiums within child-targeted TV advertising for children's fast-food meals is deceptive.
A team of Monash University researchers led by Professor James Whisstock has made a major breakthrough in the international fight against malaria, which claims the life of a child across the world every 30 seconds.
Nearly anyone touched by ovarian cancer will tell you: it's devastating. It's bad enough that cancer in almost 80 percent of patients reaches advanced stages before diagnosis, and that most patients are expected to die within five years. But just as painfully, roughly one quarter of women diagnosed have no warning that they are resistant to platinum-based chemotherapy, the main line of defense, nor that they will likely have 18 months to live.
Pharmalink AB, a privately held Swedish pharmaceutical company, has received orphan drug designation by the US Food and Drug Administration (FDA) for its product candidate Nefecon (PL-56) for patients with IgA nephropathy, also referred to as Berger's Disease. This program is presently in clinical development phase II.
› Verified 7 days ago
Mr. David Alaric Winters, LMLP Psychologist Medicare: Not Enrolled in Medicare Practice Location: 1804 Glendale, Salina, KS 67401 Phone: 785-823-5006 | |
Denise Puerto, Psychologist Medicare: Medicare Enrolled Practice Location: 730 Holly Ln, Salina, KS 67401 Phone: 785-452-4948 Fax: 785-452-6119 | |
Darrin Edwin Sewell, LMLP Psychologist Medicare: Not Enrolled in Medicare Practice Location: 5097 W Cloud St, Salina, KS 67401 Phone: 785-825-0563 Fax: 785-825-0623 | |
Everett Deane Dehaven, PH.D. Psychologist Medicare: Accepting Medicare Assignments Practice Location: 809 Elmhurst Blvd, Salina, KS 67401 Phone: 785-823-6322 Fax: 785-823-3109 | |
Vesna M Matic-wright, LMLP Psychologist Medicare: Not Enrolled in Medicare Practice Location: 509 E Elm St, Salina, KS 67401 Phone: 785-825-0541 Fax: 785-825-4024 | |
Mrs. Nicole Elise Stewart, LMLP Psychologist Medicare: Not Enrolled in Medicare Practice Location: 645 E Iron Ave, Suite C, Salina, KS 67401 Phone: 785-823-0001 Fax: 785-914-5250 | |
Jeffrey Dohm, LCP Psychologist Medicare: Not Enrolled in Medicare Practice Location: 809 Elmhurst Blvd, Salina, KS 67401 Phone: 785-823-6322 Fax: 785-823-3109 |